Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Official Makes Case in Favor of FDA LDT Guidance

Despite criticism from clinical labs, he says FDA will continue to pursue regulation of lab-developed tests

IN THIS EXCLUSIVE NEWS COVERAGE of a public appearance by a key FDA official, THE DARK REPORT provides lab executives and pathologists with a more nuanced understanding about the thinking behind the proposed FDA LDT guidance. Among the interesting insights are that FDA officials will not be surprised if some labs file a lawsuit challenging …

Official Makes Case in Favor of FDA LDT Guidance Read More »

To access this post, you must purchase The Dark Report.

Comments

;